Overview
Jeffrey Gelfand is an Infectious Disease provider practicing medicine in Boston, Massachusetts.
His clinical expertise encompasses Methicillin-Resistant Staphylococcus Aureus (MRSA) and Babesiosis.
He is actively involved in clinical research, co-authoring 20 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
Locations
55 Fruit St, Boston, MA 2114.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Fenway Community Health Center Inc.
Kenneth Mayer is an Infectious Disease provider practicing medicine in Boston, Massachusetts. Dr. Mayer is highly rated in 9 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Syphilis, Gonorrhea, Chlamydia, and Tissue Biopsy.
Office
Isaac Bogoch is an Infectious Disease provider practicing medicine in Boston, Massachusetts. Dr. Bogoch is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Typhoid Fever, Salmonella Enterocolitis, Distomatosis, and Schistosomiasis.
Office
Michael Klompas is an Infectious Disease provider practicing medicine in Boston, Massachusetts. Dr. Klompas is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Hospital-Acquired Pneumonia, Pneumonia, Sepsis, and Severe Acute Respiratory Syndrome (SARS).
Frequently Asked Questions about Dr. Jeffrey Gelfand
How do I make an appointment with Dr. Jeffrey Gelfand?
You can book an appointment with Dr. Jeffrey Gelfand by calling their office at 617-726-1796. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Jeffrey Gelfand a top-rated expert for Methicillin-Resistant Staphylococcus Aureus (MRSA)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jeffrey Gelfand is classified as an Experienced expert for Methicillin-Resistant Staphylococcus Aureus (MRSA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Jeffrey Gelfand specialize in?
While Dr. Jeffrey Gelfand is a Infectious Disease, they have specific expertise in Methicillin-Resistant Staphylococcus Aureus (MRSA), Babesiosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.
Does Dr. Jeffrey Gelfand participate in research or clinical trials?
Yes. Dr. Jeffrey Gelfand has published 20 articles and abstracts on conditions like Methicillin-Resistant Staphylococcus Aureus (MRSA). You can view a list of Dr. Jeffrey Gelfand's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Jeffrey Gelfand accept my insurance?
Dr. Jeffrey Gelfand accepts most major insurance plans, including Anthem BCBS and Blue Cross Blue Shield. We recommend calling the office directly at 617-726-1796 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- BabesiosisDr. Gelfand isExperienced. Learn about Babesiosis.
- Methicillin-Resistant Staphylococcus Aureus (MRSA)